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Abstract 
Purpose: To investigate the antioxidant, anti-inflammatory, antidiabetic, cardiovascular and cytotoxic 
activities of the leaf extract and major compounds isolated from Abelia triflora R. Br. (Caprifoliaceae) 
Methods: The chloroform soluble fraction of A. triflora leaves was subjected to several column 
chromatographic separations to isolate its constituents. Anti-inflammatory and antioxidant activities were 
determined in terms of the ability to inhibit NF-kB, iNOS activity and lipoxygenase enzyme, and to 
decrease oxidative stress in HepG2 cells. Antidiabetic and cardiovascular activities were determined by 
screening for peroxisome proliferator-activated receptor alpha (PPARα) and PPARɣ agonistic activities.  
In vitro cytotoxic activity was determined against a set of four human cancer cell lines (SK-MEL, KB, BT-
549, SK-OV-3) and two non-cancerous kidney cell lines (LLC-PK1 and VERO).  Cell viability was 
measured by neutral red assay.  
Results: Three triterpene acids were isolated from the chloroform fraction namely; ursolic acid (4), 2, 3-
dihydroxy ursolic acid (5) and 2, 3, 21-trihydroxy ursolic acid (6). The results showed that ursolic acid 
exhibited potent inhibition of lipoxygenase enzyme and iNOS (inducible nitric oxide synthase) activity 
with IC50 (half-maximal inhibitory concentration) value of 13.0 µg/mL, compared to parthenolide positive 
standard (IC50, 0.3µg/mL); furthermore, it inhibited NF-kB (nuclear factor-kappa B) with IC50 of 25.0 
µg/mL, compared to parthenolide (positive standard, (IC50, 0.5 µg/mL). Also, ursolic acid possessed the 
highest cytotoxic effect against the three cell lines, SK-MEL (IC50, 14.5 µg/mL), BT-549 (IC50, 16.0 
µg/mL) and SK-OV-3 (IC50, 12.5 µg/mL). Only 2,3-dihydroxy ursolic acid activated PPARɣ (1.5-fold at 25 
µM), compared to rosiglitazone (positive standard, 3.7 fold at 10 µM) 
Conclusion: Among the investigated compounds, ursolic acid exhibited the highest anti-inflammatory 
and cytotoxic activities, while 2,3-dihydroxy ursolic acid demonstrated antidiabetic activity via  activation 
of PPARɣ. 
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Genus Abelia (Caprifoliaceae) is composed of 
around eighty species found mostly in the 
Himalayas and East Asia. Abelia is represented 
by Abelia triflora in Pakistan and is available in 
Kaghan Valley (Hazara District) [1]. Little 
phytochemical work has been done on genus 
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Abelia. Iridoid and bisiridoid glycosides have 
been isolated from Abelia grandiflora and Abelia 
chinensis [2-3]. Our previous investigation on A. 
triflora led to the isolation of five compounds from 
ethyl acetate and n-butanol fractions and their 
anticancer activities were explored [4]. 
 
The objective of the current study was to 
undertake a phytochemical investigation of the 
chloroform soluble fraction of the plant as well as 
the evaluation of the anti-inflammatory, 
antioxidant, cytotoxic, antidiabetic and 
cardiovascular activities of fractions and major 






Leaves of A. triflora (8.0 kg) were collected in 
March 2012, from Ziarat Valley, near Quetta, 
Baluchistan province, Pakistan and was 
identified by a plant taxonomist (Rasool Bakhsh 
Tareen), Department of Botany, Baluchistan 
University, Quetta; a voucher specimen (no. 300) 
was deposited in the herbarium of the 
department [4]. 
 
Extraction and isolation 
 
The leaves were shade-dried, ground (8.0 kg) 
and extracted with methanol (3 × 10 L) at room 
temperature. The combined methanol extract 
was evaporated under reduced pressure to 
obtain a thick gummy residue (500 g). It was 
suspended in water and sequentially extracted 
with the following solvents to give fractions that 
weighed; n-hexane (120 g), chloroform (90 g), 
ethyl acetate (50 g), n-butanol (80 g) and water 
soluble fraction (100 g), after their evaporation 
[4].  Isolation of compounds 1-3 was discussed in 
our previous report on the plant [4].   
 
A part of the chloroform fraction (50 g) was 
subjected to silica gel column chromatography 
and the elution was carried out with mixtures of 
chloroform-methanol in increasing order of 
polarity leading to two major sub‑fractions I‑II. 
Sub-fraction I (chloroform-methanol 9.8:0.2) was 
re-chromatographed over silica gel eluting with 
chloroform-methanol (9.5:0.5) to give afford 
compounds 4 (200 mg) and 5 (75 mg).  
 
The sub‑fraction II (chloroform-methanol 9:1) 
showed one major spot on TLC along with little 
impurities and was further purified on silica gel 
column using chloroform-methanol (8.8:1.2), to 
give afford compound 6 (15 mg). 
 
 
General experimental procedures  
 
Column chromatography was carried out on 
silica gel (Sigma-Aldrich). All chemicals used 
were purchased from Sigma Chemical Company 
(St. Louis, MO, USA).  
 
Inhibition of cellular oxidative stress assay 
 
Cellular antioxidant activity was measured in 
HepG2 cells following the method described by 
Wolfe and Liu [5], and as reported earlier [6]. In 
this procedure the ability of test samples to stop 
intracellular generation of peroxyl radicals in 
response to ABAP [2,2′-azobis (2-
amidinopropane) dihydrochloride] is measured. 
HepG2 cells were seeded at a cell density of 
60,000 cells/well and plates were incubated for 
24 h. Quercetin was used as the positive 
standard. Percent decrease in oxidative stress 
was used as a measure of the antioxidant activity 
[6]. 
 
Inhibition of iNOS activity assay 
This iNOS activity was determined using Mouse 
macrophage cell line (RAW264.7) as described 
earlier [6,7]. The cells were treated with dilutions 
of test samples for 30 minutes. The cells were 
subjected to different dilutions of test samples for 
30 minutes. This was followed by addition of 
lipopolysaccharides (LPS, 5 µg/mL) and 
incubating for 24 h. Griess reagent was used to 
measure nitric oxide (NO) level in the cell 
supernatant. The inhibition of NO production by 
the sample was determined in comparison to 
vehicle control [7]. 
 
Reporter gene assay for inhibition of NF-kB 
activity  
 
The assay was determined in human 
chondrosarcoma cells transfected with NF-kB 
luciferase plasmid construct. Inhibition of NF-kB 
activity was calculated in terms of the decrease 
in luciferase expression. Parthenolide was used 
as reference drug, and the IC50 values were 
calculated from the dose-response curves [6, 7]. 
 
Lipoxygenase inhibition assay 
 
Lipoxygenase inhibiting activity was measured by 
modifying the spectrophotometric method 
developed by Tappel [8]. Lipoxygenase enzyme 
solution was prepared as described before 
[9,10]. Control and Test of various concentrations 
(5 – 500 M), were added in each well labeled as 
test. Lipoxygenase (LOX) solution was added in 
each well including the B (enzyme), Control and 
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Test except B (substrate).The reaction was 
started by the addition of 10 L of substrate 
solution (linoleic acid, 0.5 mM, 0.12 %w/v tween 
20, in 1:2 ratio) in each well except B (enzyme). 
The absorbance was measured at 234 nm. The 
concentration of the test compound that inhibited 
lipoxygenase activity by 50 % (IC50) was 
determined [9,10]. 
 
Assessment of DPPH radical scavenging 
activity 
 
The antioxidant activity was assessed by 
measurement of scavenging ability of the 
isolated compounds on free radical 2,2’-diphenyl-
1-picryl hydrazyl (DPPH;  C18H12N5O6).  [11,12]. 
 
Evaluation of cytotoxicity 
 
The in vitro cytotoxic activity was determined 
against a set of four human cancer cell lines (SK-
MEL, KB, BT-549, SK-OV-3) and two non-
cancerous kidney cell lines ( LLC-PK1 and 
VERO). All cell lines were obtained from the 
American Type Culture Collection (ATCC, 
Rockville, MD). Cells were seeded at a density of 
25,000 cells/well and incubated for 24 h. Test 
samples were added at various concentrations 
and cells were again incubated for 48 h. At the 
end of incubation, cell viability was determined 
using Neutral Red dye according to a 
modification of the procedure of Borenfreund et 
al [13], and as reported earlier [6,14,15]. 
Doxorubicin was used as positive control while 
DMSO was used as negative control. 
 
Reporter gene assay for PPARα and PPARγ 
activation 
 
The activation of PPARα and PPARγ was 
determined using a reporter gene assay in 
HepG2 cells transfected with pSG5-PPARα and 
PPRE X3-tk-luc or pCMV-rPPARγ and 
pPPREaP2-tk-luc plasmids as described earlier 
[14].  Transfected cells were seeded in 96- well 
plates at a density of 5 x 104 cells/well and after 
24 h of incubation; the cells were exposed to 
various concentrations of test samples. 
Rosiglitazone and ciprofibrate and were used as 




Data are expressed as mean ± SD.  For multi-
variable comparisons, one-way ANOVA was 
conducted, followed by Tukey-Kramer testing 
using GraphPad InStat software (version 3.1). 





The chloroform soluble fraction of the methanol 
extract of the leaves of A. triflora was subjected 
to a series of column chromatographic 
separations. Three compounds, namely, ursolic 
acid (4), 2, 3-dihydroxy ursolic acid (5) and 2, 3, 
21-trihydroxy ursolic acid (6) were obtained 
(Figure 1). To the best of our knowledge, this is 
the first report of the isolation of ursolic acid 
based triterpenes from genus Abelia. The 
structures of the isolated compounds were 
established by UV, IR, MS and NMR 
spectroscopy. Three of our previously isolated 
compounds, 5,6,7,4-tetrahydroxy flavone 1, 
caffeic acid 2, abeliaside 3 [4], and the three 
triterpenes (4-6) that were isolated in this study, 
were all subjected to the biological investigation. 
 
Anti-inflammatory and antioxidant activities 
 
From the results seen in Table 1, the chloroform, 
ethyl acetate and n-butanol soluble fractions 
showed a decrease of 49, 55 and 51 % in the 
oxidative stress at 1000 µg/mL concentration in 
the cellular antioxidant assay using ABAP-
induced HepG2 cells, respectively. Compounds 
1-3 and 5 showed a decrease of 40 – 65 % in the 
oxidative stress at 250 µg/ml concentration, while 
compounds 4 and 6 were inactive.  
 
The chloroform fraction and ursolic acid (4) 
inhibited iNOS activity with IC50 values of 30 and 
13 µg/mL in lipopolysaccharide (LPS)-induced 
macrophages, while compounds1-3 were 
inactive and 5 was weakly active (IC50 42 
µg/mL). Ursolic acid (4) was the only compound 
effective in inhibiting the NF-kB activity with an 
IC50 value of 25 µg/ml, compared to the positive 
standard Parthenolide. The NF-kB activity was 
lost in dihydroxy and trihydroxyursolic acids (5 
and 6). 
 
For the DPPH scavenging assay results shown 
in Table 2, compounds 1-3 exhibited moderate 
antioxidant activities compared with the positive 
control. As for the results of the lipoxygenase 
inhibitory effect seen in Table 2, compound 4 
showed a potent inhibitory potential, while 





Among the tested compounds only ursolic acid 
(4) exhibited cytotoxic activity against three 
human cancer cell lines including melanoma 
(SK-MEL), breast cancer (BT-549), and ovarian 
cancer (SK-OV-3) with IC50 values of 14.5, 16.0 
and 12.5, respectively. The compound was also 
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toxic to the two normal kidney cell lines, African 
Green Monkey kidney fibroblast (VERO) and pig 
kidney epithelial (LLC-PK1) cells with IC50 values 
15.0 and 13.3, respectively. In contrast, 2,3-
dihydroxy and 2,3,21-trihydroxyursolic acids 



































Figure 1: Structures of compounds 1-6 
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Table 1: Anti-inflammatory activity of A. triflora fractions and isolated compounds 
 
Sample  Reduction in oxidative stress (%) 
Inhibition of NF-
kB activity  
(IC50, µg/mL) 
Inhibition of iNOS 
activity (IC50, 
µg/mL) 
Chloroform fraction 49 ± 0.15a NA 30 ± 0.32a 
Ethyl acetate fraction 55 ± 0.18a NA NA 
n-butanol fraction 51 ± 0.23a NA NA 
1 65 ± 0.30a NA NA 
2 64 ± 0.19a NA NA 
3 58 ± 0.17a NA NA 
4 NA 25 ± 0.18a 13 ± 0.28a 
5 40 ± 0.25a NA 42 ± 0.36a 
6 NA NA NA 
Parthenolide* - 0.5 ± 0.21 0.3 ± 0.23 
Quercetin 50 µM* 75 ± 0.19               -               - 
At 1000 µg/mL for extract and 250 µg/mL for pure compounds, *Standard error of the mean of 3 assays, ap < 
0.0001 compared to positive control, NA = no activity 
 
Table 2: In vitro inhibition of lipoxygenase and DPPH-










1 98.7 ± 0.23a 44.8 ± 0.15a 
2 93.6 ± 0.77a 42.6 ± 0.51a 
3 91.5 ± 0.54a 40.1 ±0.34a 
4 > 200 uM 28.4 ± 0.54a 
5 > 200 uM 39.6 ±0.14a 
6 > 200 uM 42.2 ±0.22a 
BHA** 44.2 ± 0.12 - 
Baicalein** - 22.6±0.08 
*SEM (n = 5); ap < 0.0001 compared to positive 
control** 
 
Table 3: PPAR agonistic activity of A. triflora fractions 







Chloroform NA NA 
n-butanol 1.4±0.23a NA 
1 NA NA 
2 NA NA 
3 NA NA 
4 NA NA 
5 NA 1.5±0.28a 
6 NA NA 
Ciprofibrate 2.2±0.25   
Rosiglitazone    3.7±0.36 
*Standard error of the mean of 3 assays, ap< 0.0001 
compared to positive control, ** fold induction at 50 
µg/mL of fractions, 25 µg/mL of compounds 1-6, and 
10 µM of positive controls 
 
The peroxisome proliferator activated receptors 
(PPARα and PPARγ) are ligand dependent 
transcription factors that regulate the 
carbohydrate and lipid metabolism as well as 
inflammatory process. These are all considered 
significant targets related to metabolic disorder 
which is a combination of cardiovascular 
disease, diabetes, and inflammation [18]. 
Although ursolic acid (4) did not show any 
activation of PPARα or PPARγ, 2,3-dihydroxy 
ursolic acid (5) caused an increase of 1.5 fold in 
PPARγ activity at 25 µg/mL, compared to the 




The study resulted in the isolation of more 
bioactive metabolites (4-6) from A. triflora, which 
adds to the new reports on the plant. Results of 
the biological assaysindicated that among the 
tested compounds, only ursolic acid (4) 
demonstrated anti-inflammatory activities in 
terms of multiple targets, contributing to the 
beneficial effects of this plant. . Among the three 
tested triterpene acids (4-6), ursolic acid was 
found to be the most active as anti-inflammatory, 
which indicates that the hydroxylation at 
positions 2 and 21 seemed to weaken its activity. 
This is in agreement with previous literature 
which demonstrates the anti-inflammatory activity 
of ursolic acid [19,20]. Our results also proved 
that ursolic acid was the most active as cytotoxic 
constituent. This is in agreement with previous 
studies which confirmed the great potential of 
this triterpene acid as cytotoxic agent on different 
cell lines [21,22]. It also proves that the 
hydroxylation of ursolic acid at positions 2 and 21 
may be responsible for lowering its anti-
inflammatory and cytotoxic potential. This type of 
structure activity relationship is of utmost 
importance in natural product research. The plant 
could be also considered as a promising source 
of this valuable bioactive compound due to its 
high yield in the chloroform fraction. It is worth 
noting that ursolic acid did not show any 
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activation of PPARα or PPARγ which are 
considered as targets for cardiovascular and 
diabetic therapy. However the cardiovascular 
effects of ursolic acids have been reported in 
literature [23]. Thus, our study proved that 
PPARα may not be involved in the 
cardiovascular action of ursolic acid. 2,3-
dihydroxy ursolic acid (5) seemed to activate 
PPARγ without any effect on PPARα, which 
indicates its potential as antidiabetic drug. 
2,3,21-trihydroxy ursolic acid (6) lost this PPAR 
agonistic activity, which proves the structure 
activity relationship between the number and 
position of hydroxyl groups on the triterpene 
skeleton and the PPAR agonistic activity. To the 
best of our knowledge, this is the first report on 




This study led to the isolation of more biologically 
active compounds from A. triflora than was 
previously done. Among the investigated 
compounds, ursolic acid was the most 
biologically active as an anti-inflammatory and 
cytotoxic drug. The 2,3-dihydroxyursolic acid 
shows promising anti-diabetic potential, which 
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